Henrich Jill

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$43,064.98

Insider Activity of Henrich Jill

According to the SEC Form 4 filings, Henrich Jill, being in a position of

  1. EVP, Chief Regulatory Officer at Atara Biotherapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 31592 shares for $36,263,
    over all time since 2023-08-16, has bought 0 shares, and sold 38205 shares for $43,065.

The largest sale of all time was on 2024-05-16 and amounted to 25750 shares of Atara Biotherapeutics, Inc. for $15,888.

Biography of Henrich Jill

No biography is available at this moment.

2024-11-18SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Chief Regulatory Officer
1,000
0.0172%
$11.20$11,1980%
2024-08-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Global Head RA & Quality
963
0.0168%
$6.63$6,384-0.07%
2024-05-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Global Head RA & Quality
25,750
0.0212%
$0.62$15,888-32.6%
2024-03-04SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Global Head RA & Quality
3,879
0.0029%
$0.72$2,793-35%
2023-11-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Global Head RA & Quality
3,267
0.0026%
$0.39$1,271+19.73%
2023-08-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Global Head RA & Quality
3,346
0.0033%
$1.65$5,532-59.05%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.